The consolidation is expected to give patients across Mumbai and Maharashtra access to a broader range of routine and highly specialised diagnostic services
The Consortium is combining existing industry guidelines with new standards designed to address gaps that have slowed digital adoption
Biodegradable polymer platform builds on Evonik’s seven-decade track record in oral drug delivery
Endowment will fund academic leadership in dermatology in perpetuity, supporting research, education and mentorship
MSN Laboratories developed, manufactured, and received US Food and Drug Administration (FDA) approval for a generic equivalent to Adempas tablets in all five strengths
The deal replaces the greenfield R&D centre that Sai Parenterals had originally planned to build using funds earmarked in its IPO objects
Healthcare M&A activity totalled Rs. 19 billion during the month, with three major deals recorded
The companies are advancing ivonescimab in combination with antibody-drug conjugates (ADCs) across multiple tumour types
Procedures surge close to five-fold: Experts
Lupin Formoflo-G is a first-of-its-kind MDI that combines Glycopyrronium Bromide, Formoterol Fumarate and Fluticasone Propionate for the long-term management and treatment of moderate to severe COPD
The Differin Gel, 0.1% (OTC) market achieved annual sales of approximately $45.8 million
NICE’s recommendation is supported by positive results from the Phase 3 Balance study
Regeneron will receive $1 billion upfront from Sanofi, with up to $7 billion more available through development, regulatory and commercial milestones
Abbott said SimpleScreen CRC is designed primarily for eligible patients who decline or do not complete preferred stool-based or visual screening options
The rebrand is aimed at reflecting SPI Pharma’s evolution and its focus on helping customers tackle increasingly complex formulation challenges
Ayush services sector with its economic contribution estimated at US $36.92 billion in FY 2024-25
Multi-year investment reinforces U.S. business expansion and adds to $7 billion in U.S. pharma R&D and manufacturing expenditure over past five years
Apitoria Pharma Private Limited now owns 80% of A1 Biochem Labs (India) Private Limited
Subscribe To Our Newsletter & Stay Updated
